Schrödinger, Inc. (SDGR)
NASDAQ: SDGR · Real-Time Price · USD
17.81
+1.41 (8.60%)
At close: Aug 6, 2026, 4:00 PM EDT
17.85
+0.04 (0.22%)
After-hours: Aug 6, 2026, 7:50 PM EDT
Schrödinger Revenue
Schrödinger had revenue of $58.89M in the quarter ending June 30, 2026, with 7.54% growth. This brings the company's revenue in the last twelve months to $259.04M, up 8.88% year-over-year. In the year 2025, Schrödinger had annual revenue of $255.87M with 23.29% growth.
Revenue (ttm)
$259.04M
Revenue Growth
+8.88%
P/S Ratio
5.14
Revenue / Employee
$304,747
Employees
850
Market Cap
1.33B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 255.87M | 48.33M | 23.29% |
| Dec 31, 2024 | 207.54M | -9.13M | -4.21% |
| Dec 31, 2023 | 216.67M | 35.71M | 19.73% |
| Dec 31, 2022 | 180.96M | 43.02M | 31.19% |
| Dec 31, 2021 | 137.93M | 29.84M | 27.60% |
| Dec 31, 2020 | 108.10M | 22.55M | 26.36% |
| Dec 31, 2019 | 85.54M | 18.90M | 28.37% |
| Dec 31, 2018 | 66.64M | 10.95M | 19.65% |
| Dec 31, 2017 | 55.69M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Teladoc Health | 2.49B |
| Omnicell | 1.25B |
| GoodRx Holdings | 787.89M |
| Phreesia | 495.59M |
| Certara | 421.75M |
| HealthStream | 321.12M |
| Omada Health | 283.30M |
| Weave Communications | 248.72M |
SDGR News
- 1 day ago - Schrodinger raises FY26 drug discovery revenue view $65M-$75M from $55M-$65M - TheFly
- 1 day ago - Schrödinger Earnings Call Transcript: Q2 2026 - Transcripts
- 1 day ago - Schrödinger Earnings release: Q2 2026 - Filings
- 1 day ago - Schrödinger Quarterly report: Q2 2026 - Filings
- 1 day ago - Schrödinger Slides: Q2 2026 - Filings
- 1 day ago - Schrödinger Reports Second Quarter 2026 Financial Results - Business Wire
- 1 day ago - Schrodinger announces collaboration, software agreement with Bristol Myers - TheFly
- 1 day ago - Schrödinger Announces Strategic Collaboration and Software Agreement with Bristol Myers Squibb to Deploy AI Co-Scientist Bunsen for Agentic Drug Discovery - Business Wire